Upcoming events

    • April 10, 2019
    • 5:30 PM - 9:00 PM
    • Embassy Suites, Waltham, MA
    Register

    2019 Annual Meeting

     

    Aquablation for the Treatment of

    Benign Prostatic Hypertrophy

     

         Featured Speaker:  Dean Elterman, MD, MSc, FRCSC

            Target Audience:  Practicing Urologists, Urology Residents, Urology Fellows, Office Staff  

     

    Attendees will learn about this novel technique which has recently received FDA approval utilizes a water based technology combined with transrectal ultrasound to eliminate obstructing prostatic tissue in a minimally invasive approach.  This technology is quite different from the tradition transurethral resection or laser technology currently utilized today.

     

         

MAPU SPONSORS

AbbVie
Allergan
American Medical Systems 
Astellas Pharmaceuticals, Inc.
Astellas Pharmaceuticals, Inc.
Boston Scientific
Coloplast
Genomic Health
Janssen Biotech
Karl Storz
Know Error
Master Pharm Compounding Pharmacy
Metamark Genetics, Inc.
Neotract
New England Pathology Associates
Quantum Pathology
Retrophin
Richard Wolf Medical Instruments Corporation
Stratadx Pathology Services
United Medical Systems
Urolaze

Wild Apricot development by Webbright